Everlife Acquires Research Instruments Group and Other Laboratory Suppliers to Strengthen Presence in Strategic Life Sciences and Clinical Diagnostics Segments in Southeast Asia

SINGAPORE, March 10, 2022 /PRNewswire/ — Everlife Holdings Pte Ltd (“Everlife”), a leading market access and distribution company in India and South East Asiaannounced the completion of the acquisition of Research Instruments Group (“RI”), a leading supplier of scientific and laboratory instruments in Singapore, Malaysia, Thailand and Vietnam. Founded in 1989, the group has established itself as a trusted partner to the scientific and life science community, supplying a product line of nearly 30 leading companies, including globally recognized brands such as Cytiva, Agilent, PacBio , Nanostring, Cell Signaling Technologies, Proteintech, Twist Biosciences, Quanterix, ThermoFisher and others. RI also supplies Pure-NA and True-Pro, their own brand of reagents and consumables for genomics and protein research. RI currently employs over 70 people in 4 countries who provide a full range of services including sales, marketing, service and regulatory and logistics support.

RI’s investment joins three other transactions recently completed in Malaysia and Singapore over the past two months. The other companies, Medigene Sdn Bhd, Analisa Resources Sdn Bhd and Scientific Resources Pte Ltd, are well-established players in clinical diagnostics, analytics and life sciences with portfolios highly complementary to those of RI. Everlife already holds a leading position in the region, particularly in the field of clinical diagnostics in Malaysia, Philippines and India. The recent transactions will allow the company to consolidate its products and enter synergistic segments in analytical and life sciences, while gaining a foothold in geographies such as Thailand and Vietnam. RI and the other investments are highly strategic for Everlife and indicate an ambitious drive to strengthen the presence and product offering in one of the fastest growing regions in the world. Despite the COVID pandemic, GDP growth in Southeast Asia has shown a robust recovery and is expected to return to pre-pandemic levels in 2022. Singaporewhere RI is headquartered, the government has identified research and development as a strategic priority since the 1990s, and continues to be a key pillar of that of Singapore project to be an economy based on innovation and knowledge.

Sir. Raman GandotraEverlife CEOsaid, “RI epitomizes what Everlife seeks in business and they have become one of the leading names in the laboratory industry by consistently delivering superior products and services to their customers and managers. I am delighted to welcome the RI team to the Everlife family. , and we look forward to working together to advance our shared vision for better results in our region. »

Sir. Gregor KentCEO of Research Instrumentsalso commented, “I am impressed with the success Everlife has had in the region and believe that RI will benefit from the experience, professionalism and resources of a large multinational group, comprising marketing, IT, HR and a rigorous compliance team. We are thrilled to be part of Everlife and to reach even greater heights with their support.”

About Everlife

Everlife is the leading provider of diagnostic products and solutions for clinical and scientific laboratories in the South and South East Asia. By combining our technical expertise with a deep understanding of Asia and a passionate, results-driven approach to business, we aim to improve outcomes for our communities and improve business performance for clients and constituents. The Group represents more than 250 directors and a team of nearly 1,000 employees who operate in 7 countries. Everlife is part of the Everstone group and Cure Capital is a minority investor. To learn more, visit www.everlifeasia.com or visit us on LinkedIn.

About Finding Aids

Research Instruments is a leading distributor of scientific instruments and bioreagents for life science research, with the goal of providing next-generation tools and technologies with world-class support for applications, services maintenance and training. Founded in 1989 with offices throughout South East AsiaResearch Instruments Pte Ltd is GDP-MDS certified for the distribution of diagnostic and medical devices, bizSAFE for engineering services, and offers GMP compliant, ISO 9001 certified cold chain warehousing and logistics. more, visit www.ri.com.sg.

Everlife_Logo

Research_Instruments_Logo

Research_Instruments_Logo

SOURCEEverlife Holdings Pte. ltd.

About Emilie Brandow

Check Also

Banking in the Metaverse – The Next Frontier for Financial Services

Banks have long known that if they can capture customers’ attention when they’re young, they’re …